2021 annual financial data
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) 2021 Net margin
Takeda Pharmaceutical Company Limited American Depositary Shares (each represen…
Direct answer
Net margin was 11.76%.
Operating income was 509,269,000,000 JPY and net income was 376,005,000,000 JPY.
Operating cash flow was 1,010,931,000,000 JPY.
Get free Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,197,812,000,000 JPY
- Operating income
- 509,269,000,000 JPY
- Net income
- 376,005,000,000 JPY
- Operating cash flow
- 1,010,931,000,000 JPY
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) financial years